Research · head to head
Form Bio vs REDCap
Form Bio
Research
Computational platform for cell and gene therapy design and manufacturability
- From
- On request
- Rated
- -
REDCap
Research
Research data capture licensed free to non-profits, and not licensable at all to companies
- From
- On request
- Rated
- -
The short version
- Each has a real cost: Form Bio the company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.; REDCap a for-profit company cannot hold a licence or self-host REDCap, so a biotech or CRO that liked it at university simply cannot deploy it the same way and must buy a commercially licensed hosted version instead.
- They diverge on capability: Form Bio covers FormManufacturing, REDCap covers Form and survey designer.
- Prices and features above were last checked on 31 August 2026.
Where they differ
Only the attributes on which Form Bio and REDCap actually diverge.
Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in Form Bio
- FormManufacturing
- Payload design optimisation
- Genome integrity analysis
- Manufacturability prediction
- In silico workflows
- Scale-up monitoring
- Cell and gene therapy focus
- Collaboration
Only in REDCap
- Form and survey designer
- Longitudinal projects
- Data quality rules
- Randomisation
- Audit trail and e-signature
- API and exports
What people use each for
The jobs each tool is most often brought in to do.
Form Bio
- A gene therapy developer discovering manufacturability problems with an AAV construct late in process development and wanting to move that analysis earliernot REDCap
- A biotech comparing several candidate payload designs in silico before committing to expensive production runsnot REDCap
- A CDMO characterising what a client construct actually produces against what was specifiednot REDCap
- A programme team needing genome integrity evidence to support regulatory conversations about product consistencynot REDCap
REDCap
- An academic research group at an institution that already runs REDCap, where a new study database costs nothing beyond the time to build itnot Form Bio
- A hospital collecting patient reported outcomes where data must stay on institutional infrastructure rather than a vendor cloudnot Form Bio
- An investigator initiated trial that needs randomisation, an audit trail and statistical export without a commercial EDC budgetnot Form Bio
- A multi site academic collaboration where each site can be given scoped access to a single longitudinal projectnot Form Bio
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
Form Bio
- The company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.
- The current offering launched AAV-focused, so developers working in lentiviral, mRNA or cell therapy modalities are outside the scope the platform was built and validated for.
- No pricing is published and engagements are scoped per programme, which makes it impossible to size the commitment before entering a sales process.
- This is a young venture-funded company whose analyses feed regulatory-facing decisions, so continuity of the vendor over a multi-year development programme is a genuine diligence question rather than a formality.
- Predictive manufacturability models need real production data to be trustworthy, and the value depends on how much of that a young vendor has accumulated, which is difficult for a buyer to verify independently.
REDCap
- A for-profit company cannot hold a licence or self-host REDCap, so a biotech or CRO that liked it at university simply cannot deploy it the same way and must buy a commercially licensed hosted version instead.
- Because each institution hosts its own instance, support, uptime, backup and version currency vary by university, and a researcher has no recourse to Vanderbilt when the local instance is two years out of date.
- It is free of licence fee but not free of cost: the hosting institution carries server, security, patching and support staffing, which is why some institutions charge internal recharges per project.
- Validation for regulated use is the deploying institution responsibility, so an instance is not Part 11 compliant simply because REDCap supports the features; someone locally has to produce and maintain the evidence.
- The interface and reporting are dated compared with commercial survey and EDC tools, and complex logic is built through data dictionary spreadsheets rather than a modern visual builder, which slows non technical study teams.
Pricing, plan by plan
Form Bio
On request- FormManufacturing$undefined/year
- Pricing only through a sales process
- Scoped per therapeutic programme rather than per seat
- AAV-focused offering at launch
REDCap
On request- REDCap non-profit licence$undefined/year
- No licence fee to non-profit and government institutions that join the consortium
- Institution must install and host it on its own infrastructure
- For-profit organisations may not hold a licence or self-host
Which should you pick?
Choose Form Bio if
- You need formmanufacturing.
- You work on Web, Cloud.
- You also want payload design optimisation.
Choose REDCap if
- You need form and survey designer.
- You work on Web, Linux, Windows.
- You also want longitudinal projects.
Questions people ask
- Is Form Bio or REDCap better?
- Neither clearly leads. Form Bio starts at On request and REDCap at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, Form Bio or REDCap?
- Form Bio starts at On request and REDCap at On request.
- Does Form Bio or REDCap run on more platforms?
- Form Bio runs on Web, Cloud. REDCap runs on Web, Linux, Windows.
- What is Form Bio best used for?
- Form Bio is most often used for a gene therapy developer discovering manufacturability problems with an aav construct late in process development and wanting to move that analysis earlier, a biotech comparing several candidate payload designs in silico before committing to expensive production runs, a cdmo characterising what a client construct actually produces against what was specified, a programme team needing genome integrity evidence to support regulatory conversations about product consistency. Of those, a gene therapy developer discovering manufacturability problems with an aav construct late in process development and wanting to move that analysis earlier and a biotech comparing several candidate payload designs in silico before committing to expensive production runs are not what REDCap is typically brought in for.
- What can Form Bio do that REDCap cannot?
- Form Bio covers FormManufacturing, Payload design optimisation, Genome integrity analysis, Manufacturability prediction. REDCap covers Form and survey designer, Longitudinal projects, Data quality rules, Randomisation.
Answered from the vendors’ own pages
Form Bio: What does Form Bio sell now?
FormManufacturing, launched in 2026, an AAV-focused platform for predicting, optimising and monitoring manufacturability of genetic medicines from construct design through scale-up.
REDCap: Is REDCap really free?
The licence is free to non-profit institutions and government organisations that join the consortium, but they must host and support it themselves, so there is real internal cost.
Form Bio: Is it still a general bioinformatics platform?
No. It has narrowed from broad computational life sciences tooling to cell and gene therapy, and within that to AAV.
REDCap: Can my company use REDCap?
Not by holding a licence or self-hosting. For-profit organisations must use a separately licensed commercial hosted route.
Form Bio: Where did the company come from?
It spun out of Colossal Biosciences in 2022.
REDCap: Is REDCap 21 CFR Part 11 compliant?
It has the features to support Part 11 use, but compliance depends on how the hosting institution configures, validates and documents its own instance.
Form Bio: Is pricing published?
No. Engagements are scoped per programme through a sales process.
REDCap: Who supports it?
Your local institutional REDCap administrator, not Vanderbilt. Support quality varies by site.
Related pages
Other head to heads
- Form Bio vs Benchling
- Form Bio vs DNAnexus
- Form Bio vs Dotmatics
- Form Bio vs Seven Bridges
- Form Bio vs Terra
- Form Bio vs OpenEye, Cadence Molecular Sciences
- Form Bio vs Schrodinger
- Form Bio vs Sapio Sciences
- Form Bio vs Mouseflow
- Form Bio vs Chemaxon
- Form Bio vs Labguru
- Form Bio vs Obsidian
- Form Bio vs Paperpile
- Form Bio vs Reduct
- Form Bio vs Remesh
- Form Bio vs Scispot
- Form Bio vs Roam Research
- Form Bio vs Medidata Rave
- Form Bio vs SurveyMonkey
- Form Bio vs Castor EDC
- Form Bio vs Florence eBinders
- Form Bio vs SurveySparrow
- Form Bio vs GWI
- Form Bio vs Thermo SampleManager LIMS
- REDCap vs Benchling
- REDCap vs DNAnexus
- REDCap vs Dotmatics
- REDCap vs Seven Bridges
- REDCap vs Terra
- REDCap vs OpenEye, Cadence Molecular Sciences
- REDCap vs Schrodinger
- REDCap vs Sapio Sciences
- REDCap vs Mouseflow
- REDCap vs Chemaxon
- REDCap vs Labguru
- REDCap vs Obsidian
- REDCap vs Paperpile
- REDCap vs Reduct
- REDCap vs Remesh
- REDCap vs Scispot
- REDCap vs Roam Research
- REDCap vs Medidata Rave
- REDCap vs SurveyMonkey
- REDCap vs Castor EDC
- REDCap vs Florence eBinders
- REDCap vs SurveySparrow
- REDCap vs GWI
- REDCap vs Thermo SampleManager LIMS